6:00 PM, May 19, 2016 Presented by: Joseph P. Lynch, MD, Director, Bone Marrow Transplant Program at Saint Francis RSVP via phone (405) 833-2336, or e-mail to firstname.lastname@example.org, before 05/17/2016 Click Here for more information.
The U.S. Food and Drug Administration today approved Axumin, a radioactive diagnostic agent for injection. Axumin is indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated prostate specific antigen (PSA) levels following … Continued
The Centers for Medicare & Medicaid Services (CMS) released Transmittal 3508 that now requires the use of the JW modifier to report discarded drugs and biologicals from single use vials or single use packages. Previously, CMS Medicare Administrative Contractors (MACs) had … Continued